“…Light-sensitive therapies working at nearinfrared (NIR) wavelengths have been emphasized due to both their synergetic effects and minimal in vivo physiological interference, as well as various functional modules [1,2]. These therapeutics include gold nanorods [3], gold nanoshells [4], carbon nanotubes [5,6], and supramolecular nanostructures [7,8] possessing specific properties of NIR-specialized optical resonance. NIR-induced combinational nanoarchitectures have enabled spatiotemporal control of theragnostic effects with sustainable drug release [9], localized thermal ablation [10,11] and minimized off-target effects [12,13], and have been found to be effective for treating a variety of solid cancers, including those of the skin [14], breast [15] and liver [16].…”